Atlas Trials

p62/SQSTM1

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch p62/SQSTM1

RecordFirmDate
The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma (NCT01946230)National Taiwan University Hospital2014-06-01

Track p62/SQSTM1 automatically

Every clearance here is in the API, with alerts when new ones post.